OSR Health, Inc. Reports 2026 Annual Meeting Vote Results

What Happened
OSR Health, Inc. (OSRH) filed an 8-K on August 10, 2026 reporting results from its Annual Meeting (record date July 8, 2026). There were 35,118,692 shares outstanding and 21,088,120 shares (≈60.05%) present in person or by proxy, constituting a quorum. Stockholders re-elected seven directors to serve until the 2027 Annual Meeting and approved proposals to ratify the independent auditor, approve executive compensation, and increase the company’s authorized shares as described in the company’s July 16, 2026 Proxy Statement.

Key Details

• Shares outstanding (record date): 35,118,692; shares present/votes cast: 21,088,120 (≈60.05%).
• Directors re-elected (terms to 2027): Kuk Hyoun Hwang; Jun Chul Whang; Alcide Barberis; Seng Chin Mah; Hyuk Joo Jee; Joong Myung Cho; Reto Fierz. (All were elected; each received ~15.17M votes FOR with small WITHHELD counts.)
  • Example tallies: Kuk Hyoun Hwang — FOR 15,174,735; WITHHELD 129,046.
• Ratification of independent auditor: FOR 20,296,535; AGAINST 201,444; ABSTAIN 590,141.
• Executive compensation (say-on-pay) approved: FOR 15,059,135; AGAINST 83,113; ABSTAIN 161,533.
• Authorized shares increase approved: FOR 19,922,498; AGAINST 581,009; ABSTAIN 584,613. (See the Proxy Statement filed July 16, 2026 for details of the increase.)

Why It Matters
These votes confirm board continuity (all incumbent directors re-elected) and shareholder support for the company’s auditor and executive compensation program. Approval of the authorized shares increase implements the change described in the Proxy Statement and is a governance action that may affect future corporate financing or capital structure; investors should review the Proxy Statement for the exact terms and potential implications.